We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
38 hedge funds and large institutions have $55.6M invested in Corvus Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
28% more capital invested
Capital invested by funds: $43.6M → $55.6M (+$12M)
22% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 9
2.71% more ownership
Funds ownership: 70.43% → 73.14% (+2.7%)
12% less funds holding
Funds holding: 43 → 38 (-5)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
38
Holders Change
-5
Holders Change %
-11.63%
% of All Funds
0.78%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
2
Increased
11
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$1.23M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$248K |
| 3 |
Two Sigma Investments
New York
|
-$143K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$87.9K |
| 5 |
Morgan Stanley
New York
|
-$52.8K |
